ArticleBMC endocrine disorders2021

Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes.

Fu-Shun Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.